ImExHS Limited
ASX: IME
Steady revenue expansion meets profitability hurdles in medical imaging niche.
(Source: TradingView) 3-Month Performance Profile of IME on a DTF compared to S&P/ASX 200 (XJO).
ImExHS Limited posted TTM revenue of $26.32 million, reflecting 33% growth from prior year, fueled by strong half-year performance of $13.66 million and expanding cloud-based solutions. Despi
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
